|
Market Closed -
Nasdaq
21:00:00 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.150 USD | -2.27% |
|
-2.27% | -37.86% |
| 08-24 | Grace Therapeutics Files for Resale of Up to 4.8 Million Shares | MT |
| 08-13 | Grace Therapeutics, Inc. Reports Impairment charges for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.27% | -2.27% | -7.73% | -8.90% | -37.86% | -33.13% | +6.70% | -89.69% | -96.71% | 45.23M | |
| +3.31% | -3.70% | +28.80% | +57.00% | +77.63% | +61.03% | +103.64% | +21.62% | - | 70.42B | |
| +0.80% | +2.24% | +14.59% | +27.61% | +26.26% | +48.95% | +92.72% | +214.24% | +6,273.24% | 65.4B | |
| -1.31% | -0.50% | +26.00% | +22.02% | +18.24% | +7.41% | -4.29% | -69.58% | - | 28.28B | |
| -0.79% | +1.33% | +30.11% | +49.35% | +59.99% | +58.38% | +11.16% | -56.64% | - | 26.57B | |
| +0.40% | -4.80% | +16.34% | +14.26% | -28.53% | -5.89% | +469.55% | +381.94% | +840.92% | 27.16B | |
| +0.28% | +0.65% | +12.95% | +25.00% | +6.31% | +35.79% | -18.06% | -27.93% | +98.62% | 20.09B | |
| +1.02% | +6.43% | +31.28% | +96.76% | +251.66% | +269.42% | +420.34% | +1,917.81% | +966.39% | 20.61B | |
| +0.58% | -1.78% | +1.95% | +10.44% | +33.48% | +12.97% | +542.33% | - | - | 15.87B | |
| -1.09% | +3.14% | +1.32% | +12.24% | +27.99% | +46.32% | +155.12% | +194.64% | +411.86% | 13.9B | |
| +0.27% | -0.32% | +4.11% | +13.27% | +34.24% | +320.77% | +219.31% | +38.90% | +1,182.30% | 12.59B | |
| +5.22% | -0.24% | -1.03% | +2.78% | -7.46% | +26.84% | +200.51% | +559.75% | +5,626.67% | 12.45B | |
| +2.25% | +1.88% | -1.91% | +3.81% | +24.65% | +107.38% | +127.19% | +150.95% | +547.59% | 11.01B | |
| +6.51% | +8.54% | +4.17% | -16.29% | -18.64% | -47.26% | +699.44% | +75.90% | +96.38% | 11.35B | |
| +7.11% | +7.67% | +2.54% | -12.24% | -10.53% | -35.61% | +197.35% | +176.61% | - | 11.07B | |
| -12.81% | -14.06% | -8.35% | +27.09% | +185.73% | +448.68% | +615.91% | -46.89% | -36.49% | 8.25B | |
| 0.00% | -3.49% | +11.76% | +21.91% | +32.40% | +101.95% | +21.48% | +144.36% | - | 9.09B | |
| -0.02% | +0.18% | +1.33% | +130.67% | +82.26% | +174.30% | +396.72% | +278.41% | - | 9B | |
| +0.73% | +1.48% | +16.20% | +4.17% | +316.67% | +246.64% | +400.00% | -24.31% | - | 8.74B | |
| +2.36% | +3.00% | -3.91% | 0.00% | +14.31% | -6.32% | +120.05% | -17.20% | - | 8.48B | |
| Average | +0.63% | +0.54% | +9.03% | +24.05% | +54.44% | +91.93% | +238.86% | +201.20% | +1,446.44% | 19.52B | |
| Weighted average by Cap. | +1.09% | +0.70% | +15.80% | +32.10% | +52.49% | +74.66% | +193.41% | +211.25% | +2,723.44% |
- Stock Market
- Stocks
- GRCE Stock
- Sector Grace Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
